ChemoCentryx
CCXI
#3639
Rank
ยฃ2.73 B
Marketcap
ยฃ38.00
Share price
0.00%
Change (1 day)
20.15%
Change (1 year)

Earnings for ChemoCentryx (CCXI)

Earnings in 2022 (TTM): -ยฃ0.11 Billion

According to ChemoCentryx's latest financial reports the company's current earnings are ยฃ37.2 Million. In 2021 the company made an earning of -ยฃ94.35 Million a decrease over its 2020 earnings that were of -ยฃ38.54 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for ChemoCentryx from 2011 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -ยฃ0.11 Billion6.07%
2021 -ยฃ94.35 Million144.84%
2020 -ยฃ38.54 Million-1.18%
2019 -ยฃ39 Million45.17%
2018 -ยฃ26.86 Million-305.69%
2017 ยฃ13.05 M-144.7%
2016 -ยฃ29.22 Million-15.52%
2015 -ยฃ34.58 Million0.85%
2014 -ยฃ34.29 Million21.47%
2013 -ยฃ28.23 Million-1.24%
2012 -ยฃ28.58 Million906.88%
2011 -ยฃ2.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ23.68 B-24,905.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ8.66 B-9,175.04%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ1.21 B-1,371.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.02 B-6,412.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.39 B-1,557.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ16.87 B-17,779.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ5.87 B-6,250.84%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ6.81 B-7,238.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
ยฃ1.29 B-1,456.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel